(Q34086512)

30 July 2017

title

Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women (English)

1 reference

30 July 2017

de Wit H

1

1 reference

30 July 2017

Schmitt L

series ordinal

2

1 reference

30 July 2017

Purdy R

series ordinal

3

1 reference

30 July 2017

Hauger R

series ordinal

4

1 reference

30 July 2017

publication date

1 October 2001

1 reference

30 July 2017

published in

Psychoneuroendocrinology

1 reference

30 July 2017

volume

26

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

697-710

1 reference

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Anxiolytic activity of an endogenous adrenal steroid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Drug preference in normal volunteers: effects of age and time of day.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Affect and the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Assessment of cognitive performance after progesterone administration in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Drug preference and mood in humans: diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Pharmacokinetic-pharmacodynamic relationships for benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900024-5

7 January 2021

10.1016/S0306-4530(01)00024-5

Identifiers

DOI

1 reference

30 July 2017

1 reference